Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences.

Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, Brodbelt A, Jenkinson MD, Price SJ, Hamilton W, Scott SE.

Br J Gen Pract. 2019 Apr;69(681):e224-e235. doi: 10.3399/bjgp19X701861. Epub 2019 Mar 11.

2.

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.

Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD.

J Neurooncol. 2019 Apr;142(2):211-221. doi: 10.1007/s11060-019-03104-3. Epub 2019 Jan 17. Review.

3.

Extent of resection predicts risk of progression in adult pilocytic astrocytoma.

Nelson AJ, Zakaria R, Jenkinson MD, Brodbelt AR.

Br J Neurosurg. 2019 Jan 17:1-5. doi: 10.1080/02688697.2018.1549315. [Epub ahead of print]

PMID:
30653383
4.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

PMID:
30649489
5.

Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Nassiri F, Price B, Shehab A, Au K, Cusimano MD, Jenkinson MD, Jungk C, Mansouri A, Santarius T, Suppiah S, Teng KX, Toor GS, Zadeh G, Walbert T, Drummond KJ; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i32-i43. doi: 10.1093/neuonc/noy152.

PMID:
30649488
6.

VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors.

Cheng VWT, Soto MS, Khrapitchev AA, Perez-Balderas F, Zakaria R, Jenkinson MD, Middleton MR, Sibson NR.

Clin Cancer Res. 2019 Jan 15;25(2):533-543. doi: 10.1158/1078-0432.CCR-18-1889. Epub 2018 Nov 2.

PMID:
30389659
7.

An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.

Collord G, Tarpey P, Kurbatova N, Martincorena I, Moran S, Castro M, Nagy T, Bignell G, Maura F, Young MD, Berna J, Tubio JMC, McMurran CE, Young AMH, Sanders M, Noorani I, Price SJ, Watts C, Leipnitz E, Kirsch M, Schackert G, Pearson D, Devadass A, Ram Z, Collins VP, Allinson K, Jenkinson MD, Zakaria R, Syed K, Hanemann CO, Dunn J, McDermott MW, Kirollos RW, Vassiliou GS, Esteller M, Behjati S, Brazma A, Santarius T, McDermott U.

Sci Rep. 2018 Sep 10;8(1):13537. doi: 10.1038/s41598-018-31659-0.

8.

Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.

Jenkinson MD, Weber DC, Haylock BJ, Sherratt FC, Young B, Weller M, Bulbeck H, Culeddu G, Hughes DA, Brain A, Das K, Preusser M, Francis P, Gamble C.

J Neurosurg. 2018 Oct;129(4):1104-1105. doi: 10.3171/2018.6.JNS181418. Epub 2018 Aug 17. No abstract available.

9.

Predictors of early progression of surgically treated atypical meningiomas.

Budohoski KP, Clerkin J, Millward CP, O'Halloran PJ, Waqar M, Looby S, Young AMH, Guilfoyle MR, Fitzroll D, Devadass A, Allinson K, Farrell M, Javadpour M, Jenkinson MD, Santarius T, Kirollos RW.

Acta Neurochir (Wien). 2018 Sep;160(9):1813-1822. doi: 10.1007/s00701-018-3593-x. Epub 2018 Jun 30.

10.

Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy.

Islim AI, Ali A, Bagchi A, Ahmad MU, Mills SJ, Chavredakis E, Brodbelt AR, Jenkinson MD.

J Neurooncol. 2018 Oct;140(1):123-134. doi: 10.1007/s11060-018-2941-2. Epub 2018 Jun 29.

11.

Surgical management and long-term outcome of intracranial subependymoma.

Varma A, Giraldi D, Mills S, Brodbelt AR, Jenkinson MD.

Acta Neurochir (Wien). 2018 Sep;160(9):1793-1799. doi: 10.1007/s00701-018-3570-4. Epub 2018 Jun 18. Review.

12.

Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios.

Gray E, Butler HJ, Board R, Brennan PM, Chalmers AJ, Dawson T, Goodden J, Hamilton W, Hegarty MG, James A, Jenkinson MD, Kernick D, Lekka E, Livermore LJ, Mills SJ, O'Neill K, Palmer DS, Vaqas B, Baker MJ.

BMJ Open. 2018 May 24;8(5):e017593. doi: 10.1136/bmjopen-2017-017593.

13.

The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service.

Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD.

Nutr Cancer. 2018 May-Jun;70(4):643-649. doi: 10.1080/01635581.2018.1460677. Epub 2018 Apr 18.

PMID:
29668317
14.

The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review.

Martin-McGill KJ, Srikandarajah N, Marson AG, Tudur Smith C, Jenkinson MD.

CNS Oncol. 2018 Apr;7(2):CNS17. doi: 10.2217/cns-2017-0030. Epub 2018 Apr 16.

15.

Intraoperative imaging technology to maximise extent of resection for glioma.

Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD012788. doi: 10.1002/14651858.CD012788.pub2. Review.

16.

T-Cell Densities in Brain Metastases Are Associated with Patient Survival Times and Diffusion Tensor MRI Changes.

Zakaria R, Platt-Higgins A, Rathi N, Radon M, Das S, Das K, Bhojak M, Brodbelt A, Chavredakis E, Jenkinson MD, Rudland PS.

Cancer Res. 2018 Feb 1;78(3):610-616. doi: 10.1158/0008-5472.CAN-17-1720. Epub 2017 Dec 6.

17.

Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.

Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD.

Pilot Feasibility Stud. 2017 Nov 28;3:67. doi: 10.1186/s40814-017-0209-9. eCollection 2017.

18.

How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma.

Droop A, Bruns A, Tanner G, Rippaus N, Morton R, Harrison S, King H, Ashton K, Syed K, Jenkinson MD, Brodbelt A, Chakrabarty A, Ismail A, Short S, Stead LF.

Int J Cancer. 2018 Apr 15;142(8):1620-1626. doi: 10.1002/ijc.31184. Epub 2017 Dec 14.

19.

Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland.

Jamjoom AAB, Joannides AJ, Poon MT, Chari A, Zaben M, Abdulla MAH, Roach J, Glancz LJ, Solth A, Duddy J, Brennan PM, Bayston R, Bulters DO, Mallucci CL, Jenkinson MD, Gray WP, Kandasamy J, Hutchinson PJ, Kolias AG, Ahmed AI; British Neurosurgical Trainee Research Collaborative.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):120-126. doi: 10.1136/jnnp-2017-316415. Epub 2017 Oct 25.

20.

A rare case of ventriculoperitoneal shunt malfunction due to scrotal migration of the peritoneal catheter.

Foster M, Wilson G, Jenkinson MD, Buxton N.

Br J Neurosurg. 2017 Sep 26:1-8. doi: 10.1080/02688697.2017.1378802. [Epub ahead of print]

PMID:
28950733
21.

The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service.

Martin-McGill KJ, Jenkinson MD, Tudur Smith C, Marson AG.

Seizure. 2017 Nov;52:1-6. doi: 10.1016/j.seizure.2017.08.013. Epub 2017 Sep 1.

22.

Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.

Leather T, Jenkinson MD, Das K, Poptani H.

Metabolites. 2017 Jun 19;7(2). pii: E29. doi: 10.3390/metabo7020029. Review.

23.

The role of prophylactic antiepileptic drugs for seizure prophylaxis in meningioma surgery: A systematic review.

Islim AI, McKeever S, Kusu-Orkar TE, Jenkinson MD.

J Clin Neurosci. 2017 Sep;43:47-53. doi: 10.1016/j.jocn.2017.05.020. Epub 2017 Jun 16. Review.

PMID:
28625584
24.

Atypical meningioma-is it time to standardize surgical sampling techniques?

Jenkinson MD, Santarius T, Zadeh G, Aldape KD.

Neuro Oncol. 2017 Mar 1;19(3):453-454. doi: 10.1093/neuonc/now245. No abstract available.

25.

Commentary: preconceptions about the neurosurgical management of brain metastases.

Zakaria R, Jenkinson MD.

Br J Neurosurg. 2017 Jun;31(3):295. doi: 10.1080/02688697.2017.1302074. Epub 2017 Mar 15. No abstract available.

PMID:
28293961
26.

A national survey of the management of patients with incidental meningioma in the United Kingdom.

Mohammad MH, Chavredakis E, Zakaria R, Brodbelt A, Jenkinson MD.

Br J Neurosurg. 2017 Aug;31(4):459-463. doi: 10.1080/02688697.2017.1297765. Epub 2017 Mar 15.

PMID:
28292204
27.

Midbrain Gliofibroma Presenting in Adulthood following "Cure" of a Childhood Intraventricular Pilocytic Astrocytoma.

Ahmad MU, Barborie A, Pizer B, Husband D, Mallucci C, Jenkinson MD.

Pediatr Neurosurg. 2017;52(3):151-154. doi: 10.1159/000455920. Epub 2017 Mar 1.

PMID:
28245445
28.

Epilepsy and adverse quality of life in surgically resected meningioma.

Tanti MJ, Marson AG, Jenkinson MD.

Acta Neurol Scand. 2017 Sep;136(3):246-253. doi: 10.1111/ane.12711. Epub 2016 Nov 14.

PMID:
27861722
29.

Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence.

Zakaria R, Pomschar A, Jenkinson MD, Tonn JC, Belka C, Ertl-Wagner B, Niyazi M.

J Neurooncol. 2017 Feb;131(3):549-554. doi: 10.1007/s11060-016-2320-9. Epub 2016 Nov 14.

30.

Feature driven classification of Raman spectra for real-time spectral brain tumour diagnosis using sound.

Stables R, Clemens G, Butler HJ, Ashton KM, Brodbelt A, Dawson TP, Fullwood LM, Jenkinson MD, Baker MJ.

Analyst. 2016 Dec 19;142(1):98-109.

31.

A review of novel analytical diagnostics for liquid biopsies: spectroscopic and spectrometric serum profiling of primary and secondary brain tumors.

Spalding K, Board R, Dawson T, Jenkinson MD, Baker MJ.

Brain Behav. 2016 Jun 29;6(9):e00502. eCollection 2016 Sep. Review.

32.

Surgical management of posterior fossa metastases.

Sunderland GJ, Jenkinson MD, Zakaria R.

J Neurooncol. 2016 Dec;130(3):535-542. Epub 2016 Sep 12.

33.

EANO guidelines for the diagnosis and treatment of meningiomas.

Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M.

Lancet Oncol. 2016 Sep;17(9):e383-91. doi: 10.1016/S1470-2045(16)30321-7. Epub 2016 Aug 30. Review.

34.

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.

Millward CP, Brodbelt AR, Haylock B, Zakaria R, Baborie A, Crooks D, Husband D, Shenoy A, Wong H, Jenkinson MD.

Acta Neurochir (Wien). 2016 Oct;158(10):1943-53. doi: 10.1007/s00701-016-2928-8. Epub 2016 Aug 15.

PMID:
27526690
35.

Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth.

Soto MS, O'Brien ER, Andreou K, Scrace SF, Zakaria R, Jenkinson MD, O'Neill E, Sibson NR.

Oncotarget. 2016 Aug 9;7(32):52375-52391. doi: 10.18632/oncotarget.10737.

36.

Long-Term Outcomes of Endoscopic Third Ventriculostomy in Adults.

Waqar M, Ellenbogen JR, Stovell MG, Al-Mahfoudh R, Mallucci C, Jenkinson MD.

World Neurosurg. 2016 Oct;94:386-393. doi: 10.1016/j.wneu.2016.07.028. Epub 2016 Jul 17.

PMID:
27436208
37.

Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.

Zakaria R, Platt-Higgins A, Rathi N, Crooks D, Brodbelt A, Chavredakis E, Lawson D, Jenkinson MD, Rudland PS.

Br J Cancer. 2016 May 10;114(10):1101-8. doi: 10.1038/bjc.2016.103. Epub 2016 Apr 21.

38.

A quest towards personalised medicine for grade II meningiomas--will need to zoom in.

Santarius T, Jenkinson MD, Kirollos RW.

Acta Neurochir (Wien). 2016 May;158(5):931-2. doi: 10.1007/s00701-016-2774-8. Epub 2016 Mar 28. No abstract available.

PMID:
27020443
39.

The impact of epilepsy on the quality of life of patients with meningioma: A systematic review.

Tanti MJ, Marson AG, Chavredakis E, Jenkinson MD.

Br J Neurosurg. 2016;30(1):23-8. doi: 10.3109/02688697.2015.1080215. Epub 2015 Sep 7. Review.

PMID:
26982950
40.

Cell cycle progression in glioblastoma cells is unaffected by pathophysiological levels of hypoxia.

Richards R, Jenkinson MD, Haylock BJ, See V.

PeerJ. 2016 Mar 3;4:e1755. doi: 10.7717/peerj.1755. eCollection 2016.

41.

Incidental Pineal Cysts: Is Surveillance Necessary?

Nevins EJ, Das K, Bhojak M, Pinto RS, Hoque MN, Jenkinson MD, Chavredakis E.

World Neurosurg. 2016 Jun;90:96-102. doi: 10.1016/j.wneu.2016.02.092. Epub 2016 Mar 2.

PMID:
26944882
42.

Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy.

Hands JR, Clemens G, Stables R, Ashton K, Brodbelt A, Davis C, Dawson TP, Jenkinson MD, Lea RW, Walker C, Baker MJ.

J Neurooncol. 2016 May;127(3):463-72. doi: 10.1007/s11060-016-2060-x. Epub 2016 Feb 13.

43.

Long-term follow-up of endoscopic third ventriculostomy performed in the pediatric population.

Stovell MG, Zakaria R, Ellenbogen JR, Gallagher MJ, Jenkinson MD, Hayhurst C, Mallucci CL.

J Neurosurg Pediatr. 2016 Jun;17(6):734-8. doi: 10.3171/2015.11.PEDS15212. Epub 2016 Feb 12.

PMID:
26870897
44.

Introducing Discrete Frequency Infrared Technology for High-Throughput Biofluid Screening.

Hughes C, Clemens G, Bird B, Dawson T, Ashton KM, Jenkinson MD, Brodbelt A, Weida M, Fotheringham E, Barre M, Rowlette J, Baker MJ.

Sci Rep. 2016 Feb 4;6:20173. doi: 10.1038/srep20173.

45.

Combining random forest and 2D correlation analysis to identify serum spectral signatures for neuro-oncology.

Smith BR, Ashton KM, Brodbelt A, Dawson T, Jenkinson MD, Hunt NT, Palmer DS, Baker MJ.

Analyst. 2016 Jun 7;141(12):3668-78. doi: 10.1039/c5an02452h.

46.

WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?

Gallagher MJ, Jenkinson MD, Brodbelt AR, Mills SJ, Chavredakis E.

Clin Neurol Neurosurg. 2016 Feb;141:117-21. doi: 10.1016/j.clineuro.2016.01.006. Epub 2016 Jan 8.

PMID:
26780494
47.

Early adjuvant radiotherapy in the treatment of atypical meningioma.

Jenkinson MD, Waqar M, Farah JO, Farrell M, Barbagallo GM, McManus R, Looby S, Hussey D, Fitzpatrick D, Certo F, Javadpour M.

J Clin Neurosci. 2016 Jun;28:87-92. doi: 10.1016/j.jocn.2015.09.021. Epub 2016 Jan 8.

PMID:
26775147
48.

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.

Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, Bulbeck H, Das K, Farrell M, Looby S, Hickey H, Preusser M, Mallucci CL, Hughes D, Gamble C, Weber DC.

Trials. 2015 Nov 14;16:519. doi: 10.1186/s13063-015-1040-3.

49.

Genetics and imaging of oligodendroglial tumors.

Ellenbogen JR, Walker C, Jenkinson MD.

CNS Oncol. 2015;4(5):307-15. doi: 10.2217/cns.15.37. Epub 2015 Oct 19. Review.

50.

Preferential germline usage and VH/VL pairing observed in human antibodies selected by mRNA display.

Chen L, Kutskova YA, Hong F, Memmott JE, Zhong S, Jenkinson MD, Hsieh CM.

Protein Eng Des Sel. 2015 Oct;28(10):427-35. doi: 10.1093/protein/gzv042. Epub 2015 Sep 2.

PMID:
26337062

Supplemental Content

Loading ...
Support Center